These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 37731079)

  • 1. Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology.
    Fan X; Yang G; Duru F; Grilli M; Akin I; Zhou X; Saguner AM; Ei-Battrawy I
    Stem Cell Rev Rep; 2023 Nov; 19(8):2683-2708. PubMed ID: 37731079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes.
    De Bortoli M; Meraviglia V; Mackova K; Frommelt LS; König E; Rainer J; Volani C; Benzoni P; Schlittler M; Cattelan G; Motta BM; Volpato C; Rauhe W; Barbuti A; Zacchigna S; Pramstaller PP; Rossini A
    Comput Struct Biotechnol J; 2023; 21():1759-1773. PubMed ID: 36915380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models.
    Chua CJ; Morrissette-McAlmon J; Tung L; Boheler KR
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Signature of Arrhythmogenic Cardiomyopathy.
    Volani C; Rainer J; Hernandes VV; Meraviglia V; Pramstaller PP; Smárason SV; Pompilio G; Casella M; Sommariva E; Paglia G; Rossini A
    Metabolites; 2021 Mar; 11(4):. PubMed ID: 33805952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells.
    Reisqs JB; Moreau A; Sleiman Y; Boutjdir M; Richard S; Chevalier P
    Front Physiol; 2023; 14():1191965. PubMed ID: 37250123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy.
    Patel V; Asatryan B; Siripanthong B; Munroe PB; Tiku-Owens A; Lopes LR; Khanji MY; Protonotarios A; Santangeli P; Muser D; Marchlinski FE; Brady PA; Chahal CAA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
    Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy.
    Shinomiya H; Kato H; Kuramoto Y; Watanabe N; Tsuruda T; Arimura T; Miyashita Y; Miyasaka Y; Mashimo T; Takuwa A; Motooka D; Okuzaki D; Matsuoka K; Tsukamoto O; Hakui H; Yamada N; Lee JK; Kioka H; Kitakaze M; Takashima S; Sakata Y; Asano Y
    FASEB J; 2021 Nov; 35(11):e21994. PubMed ID: 34674311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.
    Miles C; Finocchiaro G; Papadakis M; Gray B; Westaby J; Ensam B; Basu J; Parry-Williams G; Papatheodorou E; Paterson C; Malhotra A; Robertus JL; Ware JS; Cook SA; Asimaki A; Witney A; Ster IC; Tome M; Sharma S; Behr ER; Sheppard MN
    Circulation; 2019 Apr; 139(15):1786-1797. PubMed ID: 30700137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy.
    Turkowski KL; Tester DJ; Bos JM; Haugaa KH; Ackerman MJ
    Congenit Heart Dis; 2017 Mar; 12(2):226-235. PubMed ID: 28326674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic and translational mechanisms in inflammatory arrhythmogenic cardiomyopathy.
    Engel M; Shiel EA; Chelko SP
    Int J Cardiol; 2024 Feb; 397():131602. PubMed ID: 37979796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review.
    Asatryan B; Asimaki A; Landstrom AP; Khanji MY; Odening KE; Cooper LT; Marchlinski FE; Gelzer AR; Semsarian C; Reichlin T; Owens AT; Chahal CAA
    Circulation; 2021 Nov; 144(20):1646-1655. PubMed ID: 34780255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue.
    Maione AS; Pilato CA; Casella M; Gasperetti A; Stadiotti I; Pompilio G; Sommariva E
    Front Physiol; 2020; 11():279. PubMed ID: 32317983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
    Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
    J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell models of arrhythmogenic cardiomyopathy: advances and opportunities.
    Sommariva E; Stadiotti I; Perrucci GL; Tondo C; Pompilio G
    Dis Model Mech; 2017 Jul; 10(7):823-835. PubMed ID: 28679668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic cardiomyopathy: a disease of intercalated discs.
    Calore M; Lorenzon A; De Bortoli M; Poloni G; Rampazzo A
    Cell Tissue Res; 2015 Jun; 360(3):491-500. PubMed ID: 25344329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
    Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Zebrafish Animal Model to Study the Genetic Underpinning and Mechanism of Arrhythmogenic Cardiomyopathy.
    Niu Y; Sun Y; Liu Y; Du K; Xu X; Ding Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.
    Boogerd CJ; Lacraz GPA; Vértesy Á; van Kampen SJ; Perini I; de Ruiter H; Versteeg D; Brodehl A; van der Kraak P; Giacca M; de Jonge N; Junker JP; van Oudenaarden A; Vink A; van Rooij E
    Cardiovasc Res; 2023 Mar; 119(2):477-491. PubMed ID: 35576477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.